Chugin Infinity Fund 3's Strategic Investment in xCARE
Chugin Capital Partners, represented by Hiroyuki Okada and based in Okayama City, has recently announced an additional investment in xCARE, a healthcare expert platform based in Shibuya, Tokyo. This funding follows xCARE's preceding Pre-Series A round in January 2024 and will be utilized for their Series A round in May 2026.
About xCARE
Founded on January 31, 2022, by Masashi Fukunaga, xCARE specializes in connecting pharmaceutical companies, medical device manufacturers, biotech ventures, and academic institutions with qualified experts required for medical development projects. By streamlining the matching of skilled professionals with precise industry needs, xCARE aims to accelerate product development timelines while improving success rates in the highly regulated medical sector.
The Challenge in Medical Development
The development of pharmaceuticals and medical devices often encounters hurdles due to the diverse expertise required across different projects. Each project can demand unique knowledge in regulatory affairs, clinical development, quality assurance, and business development, which makes it challenging to assemble the right talent in a timely manner.
xCARE addresses this issue through its extensive network of over 2,000 experts located both domestically and internationally. This approach guarantees the availability of necessary professionals when they are most needed, ensuring that projects can proceed without unnecessary delays.
Global Expansion and Innovations
In recent years, xCARE's operations have expanded to include more international initiatives, reinforcing its role as a global platform for medical product development. Plans are in place to enhance their matching capabilities with the incorporation of AI technology, which aims to improve the efficiency of expert searches and enhance matching accuracy.
Future goals include broader outreach to international clients, further expansion of the expert network, and the continual advancement of the AI matching function. By building an even more robust global expert platform, xCARE is well-positioned to tackle ongoing challenges faced in the medical field.
Collaborative Efforts for Regional Development
Chugin Financial Group emphasizes its commitment to supporting academia and healthcare-related businesses in the Chugoku and Shikoku regions through collaboration with xCARE. This partnership aims to foster innovations in the healthcare sector, ultimately benefiting regional society and its development.
Investment Overview
Here’s a quick overview of the investment details:
- - Company Name: xCARE Co., Ltd.
- - Headquarters: Shibuya, Tokyo
- - Representative: Masashi Fukunaga
- - Established: January 31, 2022
- - Business Focus: Building a specialized expert platform for the pharmaceuticals and medical devices industry, supporting development projects.
- - Website: Corporate | Services
Comments from xCARE CEO Masashi Fukunaga
Fukunaga expressed his gratitude for the continued support from Chugin, emphasizing the growth that xCARE has achieved with over 1,000 independent experts registered in both domestic and international markets. He highlighted the company's mission to revolutionize industry norms by offering a third option for hiring—contracting experts as an alternative to traditional hiring or full outsourcing. This approach allows companies to build expertise while maintaining control over flexible projects.
Fukunaga stated, "Within the medical field, we aspire to navigate beyond just recruitment challenges. We aim to spread our unique alternative to contract work and contribute significantly to industry-wide advancements.”
This investment further solidifies the partnership between Chugin and xCARE, paving the way for enhanced innovation in the ever-evolving healthcare landscape.